Project description
Novel targets to improve allogeneic hematopoietic stem cell transplantation
B cells are pivotal in chronic graft-versus-host disease (cGVHD), which is the most common cause of late non-relapse morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Recent single-cell RNA-sequencing studies demonstrated that AIM2 (absent in melanoma 2) is upregulated in cGVHD patient B cells. Upon DNA binding, the AIM2 protein induces AIM2 inflammasome formation and triggers pro-inflammatory cytokine secretion. Other related studies showed that the enzyme DNase1L3 regulating extracellular DNA exposure could play a pivotal role in B cell development. The EU-funded DABAT project will investigate AIM2 and DNase1L3 in human B cells and in mouse in vivo models. The research will address intrinsic molecular programmes underpinning B cell pathobiology and agents targeting B cells which can be developed for cGVHD treatment.
Fields of science
- natural sciencesbiological sciencesgeneticsDNA
- medical and health sciencesbasic medicineimmunology
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- medical and health sciencesclinical medicinetransplantation
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsenzymes
Programme(s)
Funding Scheme
MSCA-IF-GF - Global FellowshipsCoordinator
33000 Bordeaux
France
See on map
Partners (1)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
27708 Durham Nc
See on map